{"corpus_id":245806422,"paper_sha":"6b91e9568c6d54ab427eae1de72369fe838777e7","doi":"10.1126/science.abm0594","arxiv_id":null,"pmid":34990237,"pmcid":"PMC9983611","mag_id":null,"dblp_id":null,"acl_id":null,"title":"CAR T cells produced in vivo to treat cardiac injury","year":2022,"publication_date":"2022-01-07","venue":"Science","journal":{"name":"Science","pages":"91 - 96","volume":"375"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, N.I.H., Extramural"],"s2_fields_of_study":["Medicine"],"reference_count":31,"citation_count":984,"influential_citation_count":20,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adoptive Transfer","mj":false,"ui":"D019264"},{"d":"Animals","mj":false,"ui":"D000818"},{"d":"CD5 Antigens","mj":false,"qs":[{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D018956"},{"d":"Cell Engineering","mj":true,"ui":"D060846"},{"d":"Endopeptidases","mj":false,"qs":[{"q":"immunology","mj":true,"ui":"Q000276"},{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D010450"},{"d":"Fibroblasts","mj":false,"qs":[{"q":"immunology","mj":false,"ui":"Q000276"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D005347"},{"d":"Fibrosis","mj":false,"qs":[{"q":"therapy","mj":false,"ui":"Q000628"}],"ui":"D005355"},{"d":"HEK293 Cells","mj":false,"ui":"D057809"},{"d":"Heart Diseases","mj":false,"qs":[{"q":"pathology","mj":false,"ui":"Q000473"},{"q":"therapy","mj":true,"ui":"Q000628"}],"ui":"D006331"},{"d":"Heart Failure","mj":false,"qs":[{"q":"therapy","mj":false,"ui":"Q000628"}],"ui":"D006333"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Immunotherapy, Adoptive","mj":true,"ui":"D016219"},{"d":"Liposomes","mj":true,"ui":"D008081"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Membrane Proteins","mj":false,"qs":[{"q":"immunology","mj":true,"ui":"Q000276"},{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D008565"},{"d":"Mice","mj":false,"ui":"D051379"},{"d":"Mice, Inbred C57BL","mj":false,"ui":"D008810"},{"d":"Myocardium","mj":false,"qs":[{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D009206"},{"d":"Nanoparticles","mj":true,"ui":"D053758"},{"d":"RNA, Messenger","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D012333"},{"d":"Receptors, Chimeric Antigen","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"},{"q":"immunology","mj":true,"ui":"Q000276"},{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D000076962"},{"d":"Spleen","mj":false,"qs":[{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D013154"},{"d":"T-Lymphocytes","mj":false,"qs":[{"q":"immunology","mj":true,"ui":"Q000276"}],"ui":"D013601"},{"d":"Trogocytosis","mj":false,"ui":"D000088383"},{"d":"Fibroblast Activation Protein Alpha","mj":false,"ui":"D000099167"}],"chemicals":[{"n":"CD5 Antigens","ui":"D018956","reg":"0"},{"n":"Endopeptidases","ui":"D010450","reg":"EC 3.4.-"},{"n":"Liposomes","ui":"D008081","reg":"0"},{"n":"Membrane Proteins","ui":"D008565","reg":"0"},{"n":"RNA, Messenger","ui":"D012333","reg":"0"},{"n":"Receptors, Chimeric Antigen","ui":"D000076962","reg":"0"},{"n":"Fibroblast Activation Protein Alpha","ui":"D000099167","reg":"EC 3.4.21.-"},{"n":"Lipid Nanoparticles","ui":"C000711949","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Description Making CAR T cells in vivo Cardiac fibrosis is the stiffening and scarring of heart tissue and can be fatal. Rurik et al. designed an immunotherapy strategy to generate transient chimeric antigen receptor (CAR) T cells that can recognize the fibrotic cells in the heart (see the Perspective by Gao and Chen). By injecting CD5-targeted lipid nanoparticles containing the messenger RNA (mRNA) instructions needed to reprogram T lymphocytes, the researchers were able to generate therapeutic CAR T cells entirely inside the body. Analysis of a mouse model of heart disease revealed that the approach was successful in reducing fibrosis and restoring cardiac function. The ability to produce CAR T cells in vivo using modified mRNA may have a number of therapeutic applications. —PNK In vivo generation of CAR T cells by delivery of modified mRNA improves recovery in a mouse model of heart failure. Fibrosis affects millions of people with cardiac disease. We developed a therapeutic approach to generate transient antifibrotic chimeric antigen receptor (CAR) T cells in vivo by delivering modified messenger RNA (mRNA) in T cell–targeted lipid nanoparticles (LNPs). The efficacy of these in vivo–reprogrammed CAR T cells was evaluated by injecting CD5-targeted LNPs into a mouse model of heart failure. Efficient delivery of modified mRNA encoding the CAR to T lymphocytes was observed, which produced transient, effective CAR T cells in vivo. Antifibrotic CAR T cells exhibited trogocytosis and retained the target antigen as they accumulated in the spleen. Treatment with modified mRNA-targeted LNPs reduced fibrosis and restored cardiac function after injury. In vivo generation of CAR T cells may hold promise as a therapeutic platform to treat various diseases.","claims":[{"public_id":"cl_2a7af4372c2b967dfd8f498fe38f31d8","status":"active","text":"CD5-targeted lipid nanoparticles delivering modified mRNA can generate transient CAR T cells entirely inside the body.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_2a7af4372c2b967dfd8f498fe38f31d8"},{"public_id":"cl_cca74248fd686b52bde437d29afe8390","status":"active","text":"In a mouse model of heart failure, the in vivo-reprogrammed CAR T cells reduced fibrosis and restored cardiac function after injury.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_cca74248fd686b52bde437d29afe8390"},{"public_id":"cl_0f731398f43ea16e8b5b35aa1c2f9547","status":"active","text":"The generated antifibrotic CAR T cells showed trogocytosis and retained the target antigen while accumulating in the spleen.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_0f731398f43ea16e8b5b35aa1c2f9547"}],"concepts":[{"public_id":"co_25a36a42bae3cf528f281db5e49c1081","status":"active","name":"CAR T cells","description":"T lymphocytes engineered to express chimeric antigen receptors that enable antigen-specific recognition.","types":["cell type","therapeutic agent"],"aliases":["chimeric antigen receptor T cells","CAR T cell"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_25a36a42bae3cf528f281db5e49c1081"},{"public_id":"co_3739beeb547b12e2d16a81f8fe69133d","status":"active","name":"antifibrotic CAR T cells","description":"CAR T cells intended to recognize and act against fibrotic cells in heart tissue.","types":["cell type","therapeutic agent"],"aliases":["therapeutic CAR T cells"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3739beeb547b12e2d16a81f8fe69133d"},{"public_id":"co_40c9cb50a0e6e2b32d56251d073e593e","status":"active","name":"CD5-targeted lipid nanoparticles","description":"Lipid nanoparticle carriers designed to deliver cargo specifically to CD5-positive T lymphocytes.","types":["delivery vehicle"],"aliases":["CD5-targeted LNPs","T cell-targeted lipid nanoparticles"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_40c9cb50a0e6e2b32d56251d073e593e"},{"public_id":"co_4a7bfdefce919a46f57fe5c4bcb4db14","status":"active","name":"spleen","description":"The organ where the antifibrotic CAR T cells accumulated in the reported experiments.","types":["organ"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4a7bfdefce919a46f57fe5c4bcb4db14"},{"public_id":"co_6390455f556680e3fc9dc4ac6d21bea4","status":"active","name":"fibrosis","description":"Scarring and stiffening of heart tissue associated with cardiac injury.","types":["condition","pathology"],"aliases":["cardiac fibrosis"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6390455f556680e3fc9dc4ac6d21bea4"},{"public_id":"co_7518523cc786e501b26c19126bd7ccb2","status":"active","name":"trogocytosis","description":"A process in which immune cells acquire membrane components or antigen from target cells.","types":["cellular process"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7518523cc786e501b26c19126bd7ccb2"},{"public_id":"co_82e1f4425a2f075bdac38eb8917f22de","status":"active","name":"mouse model of heart failure","description":"An experimental mouse disease model used to test the therapeutic approach.","types":["model","preclinical model"],"aliases":["mouse model of heart disease"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_82e1f4425a2f075bdac38eb8917f22de"},{"public_id":"co_ac18acb8a46d9950df1cb034f409eb3b","status":"active","name":"modified messenger RNA","description":"Engineered mRNA used to encode the chimeric antigen receptor for transient cell reprogramming.","types":["nucleic acid","therapeutic payload"],"aliases":["modified mRNA","mRNA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ac18acb8a46d9950df1cb034f409eb3b"},{"public_id":"co_b4009b5f64695dacaa3e5e758293fb8c","status":"active","name":"target antigen","description":"The antigen retained by the antifibrotic CAR T cells during interaction with their target.","types":["molecular target"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b4009b5f64695dacaa3e5e758293fb8c"},{"public_id":"co_d112c7cd16ce354d95e05daa3efcff5b","status":"active","name":"cardiac function","description":"The performance of the heart as assessed after injury in the reported model.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d112c7cd16ce354d95e05daa3efcff5b"}],"external_ids":{"DOI":"10.1126/science.abm0594","ArXiv":null,"PubMed":34990237,"PubMedCentral":"PMC9983611","MAG":null,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/245806422","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":636309,"paper_uid":"3ef13a3c-4fff-4f0e-a9d6-7415399aeae5","canonical_identity":{"paper_id":636309,"paper_uid":"3ef13a3c-4fff-4f0e-a9d6-7415399aeae5","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/245806422"}